Trials / Unknown
UnknownNCT01430806
Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks
Dronedarone for Patients With Recurrent ICD Shocks Due to Ventricular Arrhythmia Resistant to Their Antiarrhythmic Drug Therapy or Ablation
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Recurrent ICD shocks are a serious problem in pts with ICD. Treatment failure with other antiarrhythmics and ablation are common. Dronedarone is a new antiarrhythmic drug with ion channel properties similar to amiodarone. Several case reports have shown promising results with Dronedarone for this patient population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dronedarone arm | PO Dronedarone 400 mg BID |
| DRUG | Dronedarone | Dronedarone PO 400 MG BID |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2014-12-01
- Completion
- 2015-12-01
- First posted
- 2011-09-08
- Last updated
- 2011-09-08
Source: ClinicalTrials.gov record NCT01430806. Inclusion in this directory is not an endorsement.